15 ML daratumumab-fihj 120 MG/ML / hyaluronidase-fihj 2000 UNT/ML Injection
RxNorm concept 2375136, clinical drug (scd). Prescribable name: daratumumab-fihj 1800 MG / hyaluronidase-fihj 30,000 UNT in 15 mL Injection.
- RxCUI
- 2375136
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2375136 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
daratumumab-fihj 1800 MG / hyaluronidase-fihj 30,000 UNT per 15 mL Injection
Related concepts
- daratumumab-fihj 120 MG/ML (SCDC, consists of)
- hyaluronidase-fihj 2000 UNT/ML (SCDC, consists of)
- Injection (DF, has dose form)
- 15 ML daratumumab-fihj 120 MG/ML / hyaluronidase-fihj 2000 UNT/ML Injection [Darzalex Faspro] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2375136 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2375136 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2375136. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.